2014
DOI: 10.1158/1538-7445.am2014-3698
|View full text |Cite
|
Sign up to set email alerts
|

Abstract 3698: Hyperactive AKT pathway and reactivation of the MAPK/ERK pathway in melanoma cells resistant to dual BRAF and MEK inhibition

Abstract: In order to understand the mechanisms of resistance in melanoma cells treated with dual BRAF and MEK inhibitors, A375 and SK-Mel-28 cell lines, both harboring the BRAF V600E mutation, were treated with escalating doses of vemurafenib and cobimetinib to generate dual resistant lines. Resulting cells demonstrated 10 to 30 fold increase in resistance to the drug combination compared with the parental lines. The resistance phenotype could not be reversed by an ERK inhibitor. RNA sequencing and Western analyses rev… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…The current study focused the association between ACY1 expression and the expression of ERK1, which is a key component of an important signaling pathway involved in cell growth and immune responses, respectively (27)(28)(29). Previous studies have confirmed that SphK1 functions through this pathway and results in increased cell proliferation (28,(30)(31)(32), which indicates that ERK functions downstream of SphK1. Notably, a microarray study revealed that ACY1 silencing could induce a significant increase in ERK expression (33).…”
Section: Discussionmentioning
confidence: 96%
“…The current study focused the association between ACY1 expression and the expression of ERK1, which is a key component of an important signaling pathway involved in cell growth and immune responses, respectively (27)(28)(29). Previous studies have confirmed that SphK1 functions through this pathway and results in increased cell proliferation (28,(30)(31)(32), which indicates that ERK functions downstream of SphK1. Notably, a microarray study revealed that ACY1 silencing could induce a significant increase in ERK expression (33).…”
Section: Discussionmentioning
confidence: 96%